Meati Foods has added to its funding pot with US$150m to help complete its “mega ranch” for alternative proteins in Colorado.

The Series C round takes the start-up’s financing to date to $228m, with contributions from investors such as venture-capital firm Revolution Growth and Cultivate Next, a fund recently launched by fast-food restaurant chain Chipotle Mexican Grill.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Meati has been developing plant-based proteins using mycelium, the muscular structure found in fungi. EatMeati steaks were the first products off the block, marketed via the direct-to-consumer channel, followed by restaurants in Colorado and Arizona. The company made its retail debut this month with three outlets of Sprouts Farmers Market in its home location of Boulder, Colorado, with plans to have multiple distribution points by late next year.

Operating out of a single plant near its headquarters, Meati is building a 100,000 square-foot so-called mega-ranch facility in Thornton, Colorado, due to start shipping “late” in 2022.

Tyler Huggins, the CEO who co-founded the business with chief technology officer Justin Whiteley, said: “Revolution Growth and our new and existing investors bring not just the financial firepower and ethos alignment, but deep and diversified expertise that will be instrumental in building a brand and organisation that will truly change how people eat in a way that’s better for our bodies and better for our planet.”

Mycelium makes up at least 95% of Meati’s steaks, which it says provide 17 grams of protein and 12 grams of fibre, and also contain the nutrients zinc and vitamin B12, or riboflavin.

Meati said Grosvenor Food & AgTech also contributed to the Series C funding round, along with previous investors. Acre Venture Partners, Congruent Ventures, Tao Capital and Prelude Ventures have all been prior investors via Series B and A financing rounds in 2021 and 2020, respectively.

Further products in the pipeline include chicken breasts, pork tenderloin and jerky.

Speaking to Just Food in January, Meati president Scott Tassani said: “Our goal is to exit 2025 as the market share leader and to be in a position where we’re generating roughly a quarter of the revenue for the category. There are some really nice natural tailwinds as consumers really understand that they can live healthier, experience a great product and make a big, big difference from a sustainability standpoint.”

Read the interview here: Tassani “super bullish” on US alt-meat trajectory as start-up targets $1bn sales

Just Food column: De-bunking the industry bias behind plant-based meat